Shirofune, the leading automated digital advertising management platform that services major advertising agencies worldwide ...

College students are facing a career apocalypse. To make matters worse, the outlook is likely to get even more dismal in the ...

In my 20s, solo travel was my passion and a source of joy. Now that I'm older, solo trips feel like a lonely, meaningless ...

TORONTO, ON / ACCESS Newswire / March 31, 2025 / abrdn Asia-Pacific Income Fund VCC (TSX:FAP)(UEN:T21VC0235H) (the "Company"), a ...

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

Net Income Rises 14.7% Year-Over-Year on Increased Gross Margin, Efficient OperationsProvides Initial 2025 Outlook for Further 10% Growth in ...

On May 21, 2024, the Company announced that the U.S. Food and Drug Administration (FDA) provided clearance for the Company’s investigational new drug (IND) application to proceed with a Phase 1 ...

Reiterates 2025 guidance of $80 million to $90 million in revenue and mid-40s percentage gross margin - SAN DIEGO, CA, March 31, 2025 (GLOBE ...

CHICAGO, March 31, 2025 (GLOBE NEWSWIRE) -- Pando, the leading supply chain AI company, has been recognized by Gartner as a Visionary in the 2025 Magic Quadrant for Transportation Management Systems.

Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...

FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track –– Enrolling approximately one patient per week ...

Brazil Potash management will host a webcast to provide a business update at 4:30 PM ET on Wednesday, April 9, 2025. The call will include a discussion of recent operational developments at the ...